MetLife Investment Management’s Glaukos GKOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.69M | Buy |
33,540
+3,030
| +10% | +$383K | 0.02% | 673 |
|
|
2026
Q1 | $3.28M | Sell |
30,510
-375
| -1% | -$42.2K | 0.02% | 808 |
|
|
2025
Q4 | $3.49M | Sell |
30,885
-1,849
| -6% | -$177K | 0.02% | 793 |
|
|
2025
Q3 | $2.67M | Sell |
32,734
-582
| -2% | -$53.4K | 0.01% | 947 |
|
|
2025
Q2 | $3.44M | Buy |
33,316
+4,663
| +16% | +$438K | 0.02% | 743 |
|
|
2025
Q1 | $2.82M | Sell |
28,653
-908
| -3% | -$121K | 0.02% | 884 |
|
|
2024
Q4 | $4.43M | Buy |
29,561
+1,659
| +6% | +$229K | 0.02% | 630 |
|
|
2024
Q3 | $3.64M | Sell |
27,902
-332
| -1% | -$41.3K | 0.02% | 707 |
|
|
2024
Q2 | $3.34M | Buy |
28,234
+3,909
| +16% | +$415K | 0.02% | 722 |
|
|
2024
Q1 | $2.29M | Sell |
24,325
-444
| -2% | -$39.7K | 0.02% | 899 |
|
|
2023
Q4 | $1.97M | Buy |
24,769
+186
| +0.8% | +$12.7K | 0.01% | 953 |
|
|
2023
Q3 | $1.85M | Hold |
24,583
| – | – | 0.01% | 934 |
|
|
2023
Q2 | $1.75M | Buy |
24,583
+422
| +2% | +$24.2K | 0.01% | 988 |
|
|
2023
Q1 | $1.21M | Hold |
24,161
| – | – | 0.01% | 1128 |
|
|
2022
Q4 | $1.06M | Sell |
24,161
-896
| -4% | -$44.2K | 0.01% | 1191 |
|
|
2022
Q3 | $1.33M | Hold |
25,057
| – | – | 0.01% | 1053 |
|
|
2022
Q2 | $1.14M | Hold |
25,057
| – | – | 0.01% | 1145 |
|
|
2022
Q1 | $1.45M | Buy |
25,057
+8,866
| +55% | +$469K | 0.01% | 1133 |
|
|
2021
Q4 | $720K | Hold |
16,191
| – | – | 0.01% | 1295 |
|
|
2021
Q3 | $780K | Hold |
16,191
| – | – | 0.01% | 1260 |
|
|
2021
Q2 | $1.37M | Hold |
16,191
| – | – | 0.01% | 1019 |
|
|
2021
Q1 | $1.36M | Sell |
16,191
-1,222
| -7% | -$107K | 0.01% | 998 |
|
|
2020
Q4 | $1.31M | Sell |
17,413
-1,493
| -8% | -$94.4K | 0.01% | 1007 |
|
|
2020
Q3 | $936K | Hold |
18,906
| – | – | 0.01% | 1058 |
|
|
2020
Q2 | $726K | Buy |
18,906
+2,196
| +13% | +$81.8K | 0.01% | 1179 |
|
|
2020
Q1 | $516K | Hold |
16,710
| – | – | 0.01% | 1203 |
|
|
2019
Q4 | $910K | Buy |
16,710
+1,225
| +8% | +$74.5K | 0.01% | 1141 |
|
|
2019
Q3 | $968K | Sell |
15,485
-1,223
| -7% | -$86.1K | 0.01% | 1086 |
|
|
2019
Q2 | $1.26M | Sell |
16,708
-29,630
| -64% | -$2.13M | 0.01% | 1008 |
|
|
2019
Q1 | $3.63M | Buy |
46,338
+30,892
| +200% | +$2.06M | 0.01% | 982 |
|
|
2018
Q4 | $868K | Hold |
15,446
| – | – | 0.01% | 1079 |
|
|
2018
Q3 | $1M | Hold |
15,446
| – | – | 0.01% | 1120 |
|
|
2018
Q2 | $628K | Buy |
15,446
+1,838
| +14% | +$65.4K | 0.01% | 1275 |
|
|
2018
Q1 | $420K | Hold |
13,608
| – | – | ﹤0.01% | 1471 |
|
|
2017
Q4 | $349K | Buy |
+13,608
| New | +$405K | ﹤0.01% | 1622 |
|
Other funds holding GKOS
JT
MetLife Investment Management's GKOS Position: Q2 2026 in Review
MetLife Investment Management increased its Glaukos (GKOS) stake by 9.9% in Q2 2026, buying an estimated $383K and bringing the position to 33,540 shares worth $4.69M. The position accounts for 0.02% of the portfolio, ranked #673.
MetLife Investment Management first reported a position in GKOS in Q4 2017 and has held it in 35 quarters since. 367 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.
- MetLife Investment Management held 33,540 shares of Glaukos worth $4.69M as of Q2 2026.
- MetLife Investment Management bought 3,030 Glaukos shares in Q2 2026, an estimated $383K.
- Glaukos made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #673 holding.
- MetLife Investment Management first reported a position in Glaukos in Q4 2017 and has held it in 35 quarters since.
- 367 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.